These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3572536)

  • 1. Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.
    Logan KW; Volkert WA; Holmes RA
    J Nucl Med; 1987 Apr; 28(4):505-9. PubMed ID: 3572536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
    Singh A; Holmes RA; Farhangi M; Volkert WA; Williams A; Stringham LM; Ketring AR
    J Nucl Med; 1989 Nov; 30(11):1814-8. PubMed ID: 2478681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
    Turner JH; Martindale AA; Sorby P; Hetherington EL; Fleay RF; Hoffman RF; Claringbold PG
    Eur J Nucl Med; 1989; 15(12):784-95. PubMed ID: 2483138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.
    Lattimer JC; Corwin LA; Stapleton J; Volkert WA; Ehrhardt GJ; Ketring AR; Hewett JE; Simon J; Goeckeler WF
    J Nucl Med; 1990 May; 31(5):586-93. PubMed ID: 2341893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
    Bayouth JE; Macey DJ; Kasi LP; Fossella FV
    J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Samarium-153-EDTMP biodistribution and dosimetry estimation.
    Eary JF; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison SJ; Appelbaum F
    J Nucl Med; 1993 Jul; 34(7):1031-6. PubMed ID: 7686217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal localization of samarium-153 chelates: potential therapeutic bone agents.
    Goeckeler WF; Edwards B; Volkert WA; Holmes RA; Simon J; Wilson D
    J Nucl Med; 1987 Apr; 28(4):495-504. PubMed ID: 3572535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
    Jiang CY; Zhu BL; Zhang YJ
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
    Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS
    J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
    Turner JH; Claringbold PG; Hetherington EL; Sorby P; Martindale AA
    J Clin Oncol; 1989 Dec; 7(12):1926-31. PubMed ID: 2585026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P; Nuñez R
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary investigation of dose-effect relationship of 153Sm-EDTMP in treating multiple bone metastases].
    Fan W; Chen LX; Liu XW; Tang Q; Wang GH; Zhi SF; Zeng ZY
    Ai Zheng; 2006 Nov; 25(11):1395-8. PubMed ID: 17094908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].
    Shi B; Fu Z; Lei XH
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):423-6. PubMed ID: 10920873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Samarium-153-EDTMP in bone metastases.
    Ahonen A; Joensuu H; Hiltunen J; Hannelin M; Heikkilä J; Jakobsson M; Jurvelin J; Kairemo K; Kumpulainen E; Kulmala J
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Samarium-153-EDTMP dosimetry.
    Heggie JC
    J Nucl Med; 1994 Jan; 35(1):191-2. PubMed ID: 8271053
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP.
    van Rensburg AJ; Alberts AS; Louw WK
    J Nucl Med; 1998 Dec; 39(12):2110-5. PubMed ID: 9867152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESR dosimetry of 89Sr and 153Sm in bone.
    Kinoshita A; Braga FJ; Graeff CF; Baffa O
    Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP).
    Aas M; Moe L; Gamlem H; Skretting A; Ottesen N; Bruland OS
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3148s-3152s. PubMed ID: 10541356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP.
    Goeckeler WF; Stoneburner LK; Kasi LP; Fossella FV; Price DR; Fordyce WA
    Nucl Med Biol; 1993 Jul; 20(5):657-61. PubMed ID: 8358352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia.
    Rodriguez V; Anderson PM; Litzow MR; Erlandson L; Trotz BA; Arndt CA; Khan SP; Wiseman GA
    Leuk Lymphoma; 2006 Aug; 47(8):1583-92. PubMed ID: 16966270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.